GC
GILD icon

Gilbert & Cook’s Gilead Sciences GILD Stock Holding History

Gilbert & Cook’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
3,541
+3
+0.1% +$395 0.05% 167
2026
Q1 		$493K Buy
3,538
+16
+0.5% +$2.24K 0.06% 146
2025
Q4 		$432K Buy
3,522
+12
+0.3% +$1.46K 0.05% 166
2025
Q3 		$390K Buy
3,510
+73
+2% +$8.3K 0.05% 162
2025
Q2 		$381K Buy
3,437
+75
+2% +$7.98K 0.05% 163
2025
Q1 		$377K Buy
3,362
+98
+3% +$10.1K 0.05% 156
2024
Q4 		$301K Buy
3,264
+4
+0.1% +$360 0.04% 173
2024
Q3 		$273K Sell
3,260
-4
-0.1% -$305 0.04% 186
2024
Q2 		$224K Sell
3,264
-287
-8% -$19.2K 0.03% 199
2024
Q1 		$260K Sell
3,551
-3,240
-48% -$249K 0.04% 197
2023
Q4 		$550K Buy
6,791
+344
+5% +$26.8K 0.08% 124
2023
Q3 		$483K Buy
6,447
+616
+11% +$47.4K 0.08% 127
2023
Q2 		$449K Buy
5,831
+312
+6% +$24.9K 0.07% 125
2023
Q1 		$458K Buy
5,519
+62
+1% +$5.13K 0.08% 107
2022
Q4 		$468K Buy
5,457
+90
+2% +$7.13K 0.09% 110
2022
Q3 		$418K Buy
5,367
+93
+2% +$5.86K 0.09% 118
2022
Q2 		$326K Buy
5,274
+96
+2% +$5.94K 0.06% 149
2022
Q1 		$308K Buy
5,178
+284
+6% +$18.2K 0.05% 169
2021
Q4 		$355K Buy
4,894
+172
+4% +$11.8K 0.06% 158
2021
Q3 		$330K Buy
4,722
+213
+5% +$15K 0.06% 152
2021
Q2 		$310K Buy
4,509
+110
+3% +$7.34K 0.06% 154
2021
Q1 		$284K Buy
4,399
+446
+11% +$28.8K 0.06% 159
2020
Q4 		$231K Buy
3,953
+576
+17% +$34.8K 0.05% 167
2020
Q3 		$213K Buy
3,377
+316
+10% +$21.9K 0.05% 143
2020
Q2 		$236K Buy
3,061
+286
+10% +$21.9K 0.06% 128
2020
Q1 		$207K Buy
+2,775
New +$192K 0.06% 112
2018
Q1 		– Sell
-3,538
Closed -$253K – 96
2017
Q4 		$253K Buy
3,538
+420
+13% +$31.9K 0.09% 74
2017
Q3 		$253K Buy
+3,118
New +$238K 0.09% 68

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gilbert & Cook's GILD Position: Q2 2026 in Review

Gilbert & Cook increased its Gilead Sciences (GILD) stake by 0.08% in Q2 2026, buying an estimated $395 and bringing the position to 3,541 shares worth $447K. The position accounts for 0.05% of the portfolio, ranked #167.

Gilbert & Cook first reported a position in GILD in Q3 2017 and has held it in 28 quarters since. The position peaked at $550K in Q4 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Gilbert & Cook held 3,541 shares of Gilead Sciences worth $447K as of Q2 2026.
  • Gilbert & Cook bought 3 Gilead Sciences shares in Q2 2026, an estimated $395.
  • Gilead Sciences made up 0.05% of Gilbert & Cook's portfolio in Q2 2026, its #167 holding.
  • Gilbert & Cook first reported a position in Gilead Sciences in Q3 2017 and has held it in 28 quarters since.
  • Gilbert & Cook's Gilead Sciences position peaked at $550K in Q4 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gilbert & Cook's 13F filing for Q2 2026, filed 28 Jul 2026.